ScripsAmerica to Present at SeeThruEquity Microcap Investor Conference
TYSONS CORNER, VA, Oct 28, 2014 (Marketwired via COMTEX) -- ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company will present at the SeeThruEquity Microcap Investor Conference to be held on Wednesday, November 12th at the Convene Midtown East in New York City.
ScripsAmerica's team will provide a full overview of the Company's business, highlighting consistent growth from its managed specialty pharmacy. Management will be available to meet with members of the investment community during one-on-one sessions being held at the conference.
Bob Schneiderman, CEO of ScripsAmerica, commented, "We are excited to present at the upcoming SeeThruEquity conference on November 12th. ScripsAmerica offers a very compelling story and lucrative opportunity for the investment community including institutional investors and industry professionals interested in forming strategic partnerships, all of which we believe will lead to increased shareholder value."
Members of the investment community interested in meeting with the Company's management during the conference can contact its representative at SeeThruEquity and can register to attend for the conference at the following link: www.meetmax.com/sched/event_28843/investor_reg_new.html?event_id=28843&cmd=register.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The Company's research is not paid for and unbiased as it does not conduct any investment banking or commission based business. SeeThruEquity's research is contributed to by Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distributed to its opt-in investors along with Thomson Estimates, the leading estimates platform on Wall Street.
SeeThruEquity Conferences are held approximately every quarter throughout the year and host approximately 2500 industry professionals and investors who are looking for new ideas, opportunities, and corporate relationships. For more information, visit www.seethruequity.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
ScripsAmerica, Inc.
888-959-7095
Email Contact
SOURCE: ScripsAmerica
(C) 2014 Marketwire L.P. All rights reserved.
-0-
SUBJECT CODE: Manufacturing and Production
ackaging and Containers
Pharmaceuticals and Biotech:Biotech
Professional Services urchasing
Pharmaceuticals and Biotech:Equipment and Supplies
Professional Services:Other Professional Services
Pharmaceuticals and Biotech
rugs
http://www.otcmarkets.com/stock/SCRC/news
TYSONS CORNER, VA, Oct 28, 2014 (Marketwired via COMTEX) -- ScripsAmerica, Inc. (OTCBB: SCRC) today announced that the Company will present at the SeeThruEquity Microcap Investor Conference to be held on Wednesday, November 12th at the Convene Midtown East in New York City.
ScripsAmerica's team will provide a full overview of the Company's business, highlighting consistent growth from its managed specialty pharmacy. Management will be available to meet with members of the investment community during one-on-one sessions being held at the conference.
Bob Schneiderman, CEO of ScripsAmerica, commented, "We are excited to present at the upcoming SeeThruEquity conference on November 12th. ScripsAmerica offers a very compelling story and lucrative opportunity for the investment community including institutional investors and industry professionals interested in forming strategic partnerships, all of which we believe will lead to increased shareholder value."
Members of the investment community interested in meeting with the Company's management during the conference can contact its representative at SeeThruEquity and can register to attend for the conference at the following link: www.meetmax.com/sched/event_28843/investor_reg_new.html?event_id=28843&cmd=register.
About SeeThruEquity
SeeThruEquity is an equity research and corporate access firm focused on companies with less than $1 billion in market capitalization. The Company's research is not paid for and unbiased as it does not conduct any investment banking or commission based business. SeeThruEquity's research is contributed to by Thomson One Analytics (First Call), Capital IQ, FactSet, Zacks and distributed to its opt-in investors along with Thomson Estimates, the leading estimates platform on Wall Street.
SeeThruEquity Conferences are held approximately every quarter throughout the year and host approximately 2500 industry professionals and investors who are looking for new ideas, opportunities, and corporate relationships. For more information, visit www.seethruequity.com.
About ScripsAmerica, Inc.
ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Contact:
ScripsAmerica, Inc.
888-959-7095
Email Contact
SOURCE: ScripsAmerica
(C) 2014 Marketwire L.P. All rights reserved.
-0-
SUBJECT CODE: Manufacturing and Production
ackaging and Containers Pharmaceuticals and Biotech:Biotech
Professional Services
urchasing Pharmaceuticals and Biotech:Equipment and Supplies
Professional Services:Other Professional Services
Pharmaceuticals and Biotech
rugs http://www.otcmarkets.com/stock/SCRC/news
